Free Stipulation of Dismissal - District Court of Delaware - Delaware

Case 1:08-cv-00305-GMS

Document 15

Filed 07/25/2008

Page 1 of 3

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE ASTRAZENECA LP, AKTIEBOLAGET DRACO, KBI INC. and KBI-E INC., Plaintiffs, v. BARR LABORATORIES, INC. and BARR PHARMACEUTICALS, INC., Defendants. ) ) ) ) ) ) ) ) ) ) ) )

Civil Action No. 08-305-GMS

STIPULATION OF DISMISSAL OF COMPLAINT AND PROSPOSED ORDER

STIPULATION OF DISMISSAL OF COMPLAINT AND [PROPOSED] ORDER Plaintiffs AstraZeneca LP, Aktiebolaget Draco, KBI Inc. and KBI-E Inc. (collectively "Plaintiffs") hereby stipulate to dismiss the Complaint filed by Plaintiffs against Barr Pharmaceuticals, Inc. ("Barr Pharmaceuticals") in the above-captioned action. The action will continue against defendant Barr Laboratories, Inc. ("Barr Laboratories"). It is further stipulated that this dismissal is without prejudice, and is premised upon the following stipulations: 1. Barr Pharmaceuticals stipulates to be bound, to the same extent that Barr

Laboratories will be bound, by any Final Judgment in the above-captioned action regarding infringement, validity and/or enforceability of United States Patent Nos. 6,423,340 and 5,643,602 with respect to the drug product that is the subject of Barr Laboratories' Abbreviated New Drug Application ("ANDA") No. 90-379. 2. Barr Pharmaceuticals stipulates that any Order granting preliminary or permanent

injunctive relief in the above-captioned action against Barr Laboratories with respect to the approval, manufacture, importation, sale, use, or offer for sale of the drug product that is the subject of Barr Laboratories' ANDA No. 90-379 shall apply equally to Barr Pharmaceuticals.

Case 1:08-cv-00305-GMS

Document 15

Filed 07/25/2008

Page 2 of 3

3.

Barr Pharmaceuticals stipulates that, to the extent that it has documents, witnesses,

and information in its custody and control that are relevant to the Complaint against Barr Laboratories, Barr Pharmaceuticals agrees to provide Plaintiffs with such documents, witnesses and information in response to discovery requests to Barr Laboratories, to the same extent Barr Pharmaceuticals would be required to do so in response to a subpoena to a non-party. 4. The case caption should be amended to read: AstraZeneca LP, Aktiebolaget Draco,

KBI Inc. and KBI-E Inc., Plaintiffs, v. Barr Laboratories, Inc., Defendant, Civil Action No. 08-305JJF. SO STIPULATED Dated: July 25, 2008 MORRIS, NICHOLS, ARSHT & TUNNELL LLP PHILLIPS, GOLDMAN & SPENCE, P.A.

/s/ James W. Parrett, Jr.
___________________________ Jack B. Blumenfeld (#1014) James W. Parrett, Jr. (#4292) 1201 North Market Street P.O. Box 1347 Wilmington, DE 19899 (302) 658-9200 [email protected] [email protected] Attorneys for Plaintiffs OF COUNSEL: George F. Pappas Jeffrey B. Elikan Edward H. Rippey Andrea G. Reister Sarah J. Chickos Derek J. Fahnestock Covington & Burling LLP 1201 Pennsylvania Avenue, N.W. Washington D.C. 20004 (202) 662-6000

/s/ John C. Phillips, Jr.
___________________________ John C. Phillips, Jr. (#110) 1200 North Broom Street Wilmington, DE 19806 (302) 655-4200 [email protected] Attorney for Defendants

OF COUNSEL: George C. Lombardi Bradley C. Graveline Amy Flaherty Hartman Eric L. Broxterman Dana E. Schaffner Winston & Strawn LLP 35 West Wacker Drive Chicago, Illinois 60601 (312) 558-5600

2

Case 1:08-cv-00305-GMS

Document 15

Filed 07/25/2008

Page 3 of 3

SO ORDERED Dated:____________________ _________________________ Honorable Gregory M. Sleet United States District Judge

3